Protalix (PLX) Says FDA Accepts Resubmission of CRL for Taliglucerase Alfa; Sets Feb. 1 as PDUFA Date
Go back to Protalix (PLX) Says FDA Accepts Resubmission of CRL for Taliglucerase Alfa; Sets Feb. 1 as PDUFA Date| PROTALIX BIOTHERAPEUTICS, INC. COMMON STOCK (NYSE: PLX) | Delayed: 2.37 -0.01 (0.42%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.38 | 52 Week High | $1.11 | |||
| Open | $2.39 | 52 Week Low | $0.41 | |||
| Day High | $2.44 | P/E | N/A | |||
| Day Low | $2.35 | EPS | $-0.29 | |||
| Volume | 433,159 | |||||
